AAAlhoussein Alsayed AbdelAal

Alhoussein Alsayed AbdelAal

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alhoussein Alsayed AbdelAal has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Identifying Independent Predictors of Mortality in COVID-19 Patients with Mucormycosis

    by Mohamed G Hamed, Abdelmonem Awad Hegazy, Ahmed Embaby, Shimaa Abdelmoneem, Amany Abd Al Badea, Ali Awad, Mohammad Walaa, Mai Ahmed Gobran, Omnia Awwad, Doaa AbdElmonem, et al.

    Background: Coronavirus disease 2019 (COVID-19) may lead to immunosuppression, leaving patients vulnerable to secondary invasive fungal infection like mucormycosis. The present study aimed to determine whether there are any risk factors associated with mortality in mucormycosis among COVID-19 patients. Patients and Methods: Patients with COVID-19 diagnosed with mucormycosis who received treatment at University Hospitals were included in the study. Complete blood count (CBC), glycated hemoglobin (HBA1c), C-reactive protein (CRP), serum albumin level, creatinine, ferritin levels, lactate dehydrogenase (LDH), D-dimer and histopathological observations were performed for all participants’ specimens. Results: The number (N) of patients included in the study was 46. About 85 % (39/46) of patients had post-COVID-19 syndrome and the other 7 cases were in the active phase of the disease. CRP, serum ferritin, D-dimer, CRP/albumin ratio and CRP/absolute lymphocyte counts were statistically significant (P<0.05) within non-survivors as compared to survivors. After analysis of multivariate analysis that patients had oxygen support, while elevated CRP/albumin ratios were independent predictors of mortality in COVID-19 patients associated with mucormycosis. Conclusions: Mucormycosis can be caused by immunosuppression conditions associated with COVID-19 infection. Oxygen levels and C-reactive protein/albumin are independent predictors of mortality and morbidity in post COVID-19 patients.

  • Assessment of Upper Limb Muscle Function in Elderly Patients with Chronic Kidney Disease

    by Elshabrawy Mohamed Mahmoud Abd-Elnaby, Ahmed Hussein Ali Nasr-Eldin, Emam Mohammed Esmayel, Alhoussein AbdelAal

    Background: Chronic kidney disease (CKD) is recognized as a leading public health problem worldwide which is more prevalent in the elderly population. However, there is paucity of studies investigating muscle function in older adults with CKD. This study aimed to assess the function of upper limb muscles in elderly patients with CKD. Methods A case-control study was conducted, including 73 patients with CKD and 73 healthy individuals as a control group. Patients were subdivided into two groups; 37 predialysis patients and 36 patients on regular hemodialysis. History was taken, blood pressure, anthropometric measures, handgrip strength (HGS), were assessed and a blood sample was withdrawn for measuring complete blood count, random blood sugar, lipid profile, renal and liver function tests.Results There is a significant decrease in HGS in CKD patients as compared to the control group. Predialysis CKD patients have significantly higher HGS as compared to patients on regular hemodialysis. Both hemoglobin and albumin are positively correlated with HGS. Fasting triglycerides are inversely correlated with HGS. Conclusions There is a significant decline in upper limb muscle function in CKD patients. The decline in muscle function is more evident in the hemodialysis than in the predialysis CKD patients.